- Home
- FBGL vs CRIS Comparison
FBGL vs CRIS Comparison
Compare FBGL & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBGL | CRIS |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 14.6M |
| IPO Year | 2025 | 2000 |
Fundamental Metrics
Financial Performance| Metric | FBGL | CRIS |
|---|---|---|
| Price | $0.83 | $0.83 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | ★ 2.4M | 939.0K |
| Earning Date | 10-17-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $10,491,303.00 | ★ $11,650,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $0.41 | $0.77 |
| 52 Week High | $5.45 | $3.65 |
Technical Indicators
Market Signals| Indicator | FBGL | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | 24.11 |
| Support Level | $0.75 | $0.77 |
| Resistance Level | $0.93 | $1.03 |
| Average True Range (ATR) | 0.15 | 0.07 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 27.52 | 9.85 |
Price Performance
Historical ComparisonAbout FBGL FBS Global Limited Ordinary Shares
FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.